Cellomics and GE Healthcare Collaborate To Provide Faster and More Effective Cellular Screening

Software Development and Commercialization Agreement Offers Informatics Solution for High Content Screening

30-Jun-2004

Pittsburgh. Cellomics, Inc. and GE Healthcare (a combination of the former Amersham and GE Medical Systems) announced a software development and commercialization agreement aimed at facilitating faster and more efficient drug development. Under the terms of the agreement, the two companies will collaborate to develop and market an interface that permits High Content Screening (HCS) analysis utilizing both GE Healthcare's sub-cellular imaging instruments and Cellomics' high content informatics (HCi*) platform.

Under the agreement, Cellomics will develop and sell software that allows data and images generated by GE Healthcare's IN Cell Analyzer 3000 and IN Cell Analyzer 1000 sub-cellular imaging systems to be extracted and interrogated by Cellomics® Store and vHCS* Discovery ToolBox, key components of Cellomics' HCi platform. When used with the IN Cell Analyzer 3000 and IN Cell Analyzer 1000 systems, the software will enable researchers to easily store, mine and interpret data, and so make faster and more informed decisions in their drug development process.

"This collaboration with Cellomics supports GE Healthcare's strategy of helping customers improve efficiencies in gathering, analyzing, and understanding complex drug development information," said Michael Evans, vice president of marketing and strategy, Discovery Systems, GE Healthcare. "Aided by Cellomics' informatics software, users of our IN Cell Analyzer 3000 and IN Cell Analyzer 1000 systems will be able to mine and interpret data more easily."

"Our customers have found high value by utilizing our proprietary HCi solutions for the management and analysis of their HCS data," commented Daniel J. Calvo, president and CEO of Cellomics. "These tools are vital to the success of HCS programs in both drug discovery and basic life science research. We are pleased that we will be able to combine our informatics solution expertise with GE Healthcare's cellular analysis products to drive towards the ultimate goal of cutting drug development time."

https://www.bionity.com/en/news/38267/cellomics-and-ge-healthcare-collaborate-to-provide-faster-and-more-effective-cellular-screening.html